Published in Circulation on February 20, 2007
Progression is accelerated from prehypertension to hypertension in blacks. Hypertension (2011) 2.82
Reduction in blood pressure with statins: results from the UCSD Statin Study, a randomized trial. Arch Intern Med (2008) 2.24
Cardiovascular health disparities: a systematic review of health care interventions. Med Care Res Rev (2007) 1.83
Is prehypertension a risk factor for the development of type 2 diabetes? Diabetes Care (2009) 1.67
Presence of baseline prehypertension and risk of incident stroke: a meta-analysis. Neurology (2011) 1.64
Alcohol consumption in young adults and incident hypertension: 20-year follow-up from the Coronary Artery Risk Development in Young Adults Study. Am J Epidemiol (2010) 1.54
Prehypertension: epidemiology, consequences and treatment. Nat Rev Nephrol (2009) 1.28
Prehypertension, racial prevalence and its association with risk factors: Analysis of the REasons for Geographic And Racial Differences in Stroke (REGARDS) study. Am J Hypertens (2010) 1.28
Prehypertension and incidence of cardiovascular disease: a meta-analysis. BMC Med (2013) 1.22
Abdominal obesity and inflammation predicts hypertension among prehypertensive men and women: the ATTICA Study. Heart Vessels (2008) 1.15
Exercise blood pressure and future cardiovascular death in asymptomatic individuals. Circulation (2010) 1.11
Prehypertension and incident acute coronary heart disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Am J Hypertens (2013) 1.09
White coat hypertension is more risky than prehypertension: important role of arterial wave reflections. Hypertension (2013) 1.05
Relation of blood pressure components and categories and all-cause, stroke and coronary heart disease mortality in urban Chinese women: a population-based prospective study. J Hypertens (2009) 1.04
Prevalence of prehypertension in young military adults & its association with overweight & dyslipidaemia. Indian J Med Res (2011) 1.03
Prevalence of prehypertension and associated cardiovascular risk profiles among prediabetic Omani adults. BMC Public Health (2008) 1.01
Normal systolic blood pressure and risk of heart failure in US male physicians. Eur J Heart Fail (2009) 0.98
A noninvasive method for coronary artery diseases diagnosis using a clinically-interpretable fuzzy rule-based system. J Res Med Sci (2015) 0.97
Systolic blood pressure and incident heart failure in the elderly. The Cardiovascular Health Study and the Health, Ageing and Body Composition Study. Heart (2011) 0.96
A cross-sectional study of the prevalence and risk factors for hypertension in rural Nepali women. BMC Public Health (2013) 0.96
Systematic review of health disparities for cardiovascular diseases and associated factors among American Indian and Alaska Native populations. PLoS One (2014) 0.94
Prevention of hypertension in patients with pre-hypertension: protocol for the PREVER-prevention trial. Trials (2011) 0.93
Prehypertension and the risk of coronary heart disease in Asian and Western populations: a meta-analysis. J Am Heart Assoc (2015) 0.93
Awareness and control of hypertension in Bangladesh: follow-up of a hypertensive cohort. BMJ Open (2014) 0.91
Relationship of hypertension, blood pressure, and blood pressure control with white matter abnormalities in the Women's Health Initiative Memory Study (WHIMS)-MRI trial. J Clin Hypertens (Greenwich) (2010) 0.90
Effect of dietary pulses on blood pressure: a systematic review and meta-analysis of controlled feeding trials. Am J Hypertens (2013) 0.87
Hypertension is an independent risk factor for type 2 diabetes: the Korean genome and epidemiology study. Hypertens Res (2015) 0.86
Prehypertensive African-American women have preserved nitric oxide and renal function but high cardiovascular risk. Kidney Blood Press Res (2010) 0.86
Health-risk factors and the prevalence of hypertension: cross-sectional findings from a national cohort of 87,143 Thai Open University students. Glob J Health Sci (2013) 0.84
Early inflammatory and metabolic changes in association with AGTR1 polymorphisms in prehypertensive subjects. Am J Hypertens (2010) 0.83
Blood pressure, fitness, and lipid profiles of rural women in the wellness for women project. Cardiopulm Phys Ther J (2010) 0.83
Age of natural menopause and atrial fibrillation: the Framingham Heart Study. Am Heart J (2012) 0.83
Is 2015 the primetime year for prehypertension? Prehypertension: a cardiovascular risk factor or simply a risk marker? J Am Heart Assoc (2015) 0.82
Comparative study of ambulatory blood pressure monitoring and clinic blood pressure measurement in the risk assessment and management of hypertension. Sultan Qaboos Univ Med J (2010) 0.82
Effects of low-fat dairy intake on blood pressure, endothelial function, and lipoprotein lipids in subjects with prehypertension or stage 1 hypertension. Vasc Health Risk Manag (2013) 0.81
Effectiveness of tailored lifestyle interventions, using web-based and print-mail, for reducing blood pressure among rural women with prehypertension: main results of the Wellness for Women: DASHing towards Health clinical trial. Int J Behav Nutr Phys Act (2014) 0.81
Prehypertension is not associated with all-cause mortality: a systematic review and meta-analysis of prospective studies. PLoS One (2013) 0.81
Risk factors for prehypertension in the community: a prospective analysis from the Western New York Health Study. Nutr Metab Cardiovasc Dis (2013) 0.80
Impaired endogenous fibrinolytic capacity in prehypertensive men. J Hum Hypertens (2015) 0.80
Is prehypertension a risk factors for cardiovascular diseases among Iranian women? J Res Med Sci (2012) 0.79
Women have significantly greater difference between central and peripheral arterial pressure compared with men: the Bogalusa Heart Study. J Am Soc Hypertens (2013) 0.78
Does prehypertension represent an increased risk for incident hypertension and adverse cardiovascular outcome? Hypertension (2009) 0.78
Prehypertension Is Associated With Abnormalities of Cardiac Structure and Function in the Atherosclerosis Risk in Communities Study. Am J Hypertens (2015) 0.78
Pre-hypertension: another 'pseudodisease'? BMC Med (2013) 0.77
Prevalence and incident prehypertension and hypertension in postmenopausal Hispanic women: results from the Women's Health Initiative. Am J Hypertens (2014) 0.77
Prehypertension and clustering of cardiovascular risk factors among adults in suburban Beijing, China. J Epidemiol (2011) 0.77
Longitudinal Cognitive Trajectories of Women Veterans from the Women's Health Initiative Memory Study. Gerontologist (2015) 0.77
Poor drug adherence and lack of awareness of hypertension among hypertensive stroke patients in Kampala, Uganda: a cross sectional study. BMC Res Notes (2016) 0.76
Efficacy of moxibustion for pre- or stage I hypertension: study protocol for a pilot randomized controlled trial. Trials (2012) 0.75
Habitual cocoa intake reduces arterial stiffness in postmenopausal women regardless of intake frequency: a randomized parallel-group study. Clin Interv Aging (2016) 0.75
Effects of Losartan and Amlodipine on Left Ventricular Remodeling and Function in Young Stroke-Prone Spontaneously Hypertensive Rats. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2014) 0.75
Prevalence of cardiovascular risk factors among workers at a private tertiary center in Angola. Vasc Health Risk Manag (2016) 0.75
NALP3-Inflammasome-Related Gene Polymorphisms in Patients with Prehypertension and Coronary Atherosclerosis. Biomed Res Int (2016) 0.75
Prehypertension: a warning sign of future cardiovascular risk. Int J Prev Med (2014) 0.75
The Natural History of Patients With Isolated Metabolic Syndrome. Mayo Clin Proc (2016) 0.75
Self-recalled Youth Physical Activity and Postmenopausal Cardiovascular Disease. Health Behav Policy Rev (2014) 0.75
Effect of Aerobic Exercise Training on Blood Pressure in Indians: Systematic Review. Int J Chronic Dis (2016) 0.75
Abnormal phosphorylation of Tie2/Akt/eNOS signaling pathway and decreased number or function of circulating endothelial progenitor cells in prehypertensive premenopausal women with diabetes mellitus. BMC Endocr Disord (2016) 0.75
Assessing strategies for heart failure with preserved ejection fraction at the outpatient clinic. Arq Bras Cardiol (2014) 0.75
Prevalence of electrocardiographic abnormalities based on hypertension severity and blood pressure levels: the Reasons for Geographic and Racial Differences in Stroke study. J Am Soc Hypertens (2016) 0.75
Moderately elevated blood pressure during pregnancy and odds of hypertension later in life: The POUCHmoms longitudinal study. BJOG (2017) 0.75
Randomised, double-blind, placebo-controlled, assessment of the efficacy and safety of dietary supplements in prehypertension. J Hum Hypertens (2017) 0.75
Heterogeneity in Blood Pressure Transitions Over the Life Course: Age-Specific Emergence of Racial/Ethnic and Sex Disparities in the United States. JAMA Cardiol (2017) 0.75
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37
Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension (2003) 63.78
Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA (2004) 23.69
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med (2006) 18.25
Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med (2005) 15.18
Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 12.44
Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med (2006) 12.09
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA (2007) 10.50
Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med (2003) 10.06
Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. Am J Cardiol (2007) 9.62
Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med (2006) 9.40
Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med (2006) 8.73
Estrogen therapy and coronary-artery calcification. N Engl J Med (2007) 8.70
Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med (2002) 7.77
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54
Frailty: emergence and consequences in women aged 65 and older in the Women's Health Initiative Observational Study. J Am Geriatr Soc (2005) 6.73
Effects of Testosterone Treatment in Older Men. N Engl J Med (2016) 6.66
Calcium/vitamin D supplementation and cardiovascular events. Circulation (2007) 6.63
Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 6.51
Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Ann Intern Med (2006) 6.22
Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med (2006) 6.14
Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) (2002) 6.03
Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med (2004) 5.65
Lasofoxifene in postmenopausal women with osteoporosis. N Engl J Med (2010) 5.60
Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med (2005) 5.49
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association. Circulation (2011) 5.26
Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial. Lancet (2009) 5.22
The prognostic value of a nomogram for exercise capacity in women. N Engl J Med (2005) 5.03
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet (2012) 4.87
Effects of estrogen plus progestin on health-related quality of life. N Engl J Med (2003) 4.83
Design and implementation of the Hispanic Community Health Study/Study of Latinos. Ann Epidemiol (2010) 4.61
2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2014) 4.57
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2010) 4.56
Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial. Am J Epidemiol (2005) 4.55
Exercise plus behavioral management in patients with Alzheimer disease: a randomized controlled trial. JAMA (2003) 4.54
The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest (2005) 4.41
Preoperative hematocrit levels and postoperative outcomes in older patients undergoing noncardiac surgery. JAMA (2007) 4.36
Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol (2007) 4.21
Exercise capacity and the risk of death in women: the St James Women Take Heart Project. Circulation (2003) 4.19
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation (2007) 4.16
Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial. Diabetes Care (2010) 4.10
Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial. JAMA (2003) 4.07
Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. Arch Intern Med (2006) 3.91
Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. JAMA (2005) 3.89
Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA (2011) 3.85
Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA (2004) 3.85
Association of age and sex with myocardial infarction symptom presentation and in-hospital mortality. JAMA (2012) 3.66
Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst (2008) 3.60
Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative. Arch Intern Med (2010) 3.53
Estrogen plus progestin and risk of venous thrombosis. JAMA (2004) 3.46
Evidence-based guidelines for cardiovascular disease prevention in women. Circulation (2004) 3.39
Validity of self-report for fractures among a multiethnic cohort of postmenopausal women: results from the Women's Health Initiative observational study and clinical trials. Menopause (2004) 3.33
Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause. Am J Epidemiol (2009) 3.33
Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data. Lancet (2013) 3.31
Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA (2006) 3.29
Association of Clinical Researchers and Educators a statement on relationships between physicians and industry. Endocr Pract (2012) 3.27
Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Control (2002) 3.27
Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. Lancet Neurol (2011) 3.25
Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med (2002) 3.10
Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation (2012) 2.99
Recruitment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol (2007) 2.98
Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 2.97
Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial. JAMA (2003) 2.90
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association. J Am Coll Cardiol (2011) 2.89
Operative blood loss, blood transfusion, and 30-day mortality in older patients after major noncardiac surgery. Ann Surg (2010) 2.80
Association of active and passive smoking with risk of breast cancer among postmenopausal women: a prospective cohort study. BMJ (2011) 2.80
Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care (2008) 2.76